Improving but Inferior Survival in Patients with Chronic Lymphocytic Leukemia in Taiwan: A Population-Based Study, 1990-2004

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Wu, Shang Ju ^a,b   Chiang, Chun Ju ^c,d   Lin, Chien Ting ^a   Tien, Hwei Fang ^a   Lai, Mei Shu ^c,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d Taiwan Cancer Registry   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH INSURANCE; POPULATION RESEARCH; PROBABILITY; RACE DIFFERENCE; SEX DIFFERENCE; SOCIAL STATUS; SURVIVAL RATE; SURVIVAL TIME; TAIWAN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PROGNOSIS; REGISTRIES; SEX FACTORS; TAIWAN; YOUNG ADULT;

EID: 84876561457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062930     Document Type: Article

References (36)

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89: 3909-3918.
2. Anderson JR, Armitage JO, Weisenburger DD, (1998) Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 9: 717-720.
3. Rozman C, Montserrat E, (1995) Chronic lymphocytic leukemia. N Engl J Med 333: 1052-1057.
4. Chuang SS, Lin CN, Li CY, (2000) Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer 89: 1586-1592.
5. Dores GM, Anderson WF, Curtis RE, Landgren O, Ostroumova E, et al. (2007) Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol 139: 809-819.
6. Goldin LR, Slager SL (2007) Familial CLL: genes and environment. Hematology Am Soc Hematol Educ Program: 339-345.
7. Wu SJ, Huang SY, Lin CT, Lin YJ, Chang CJ, et al. (2010) The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: a distinct increasing trend with birth-cohort effect. Blood 116: 4430-4435.
8. Brenner H, Gondos A, Pulte D, (2008) Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood 111: 4916-4921.
9. Danese MD, Griffiths RI, Gleeson M, Satram-Hoang S, Knopf K, et al. (2011) An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia. Blood 117: 3505-3513.
10. Abrisqueta P, Pereira A, Rozman C, Aymerich M, Gine E, et al. (2009) Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience. Blood 114: 2044-2050.
11. Chiang CJ, Chen YC, Chen CJ, You SL, Lai MS Cancer trends in Taiwan. Jpn J Clin Oncol 40: 897-904.
12. Huang SY, Yao M, Tang JL, Lee WC, Tsay W, et al. (2007) Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years. Cancer 110: 896-905.
13. Hsu C, Shen YC, Cheng CC, Hong RL, Chang CJ, et al. (2006) Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev 15: 856-861.
14. Shen YC, Chang CJ, Hsu C, Cheng CC, Chiu CF, et al. (2005) Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev 14: 1986-1990.
15. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002) Cancer incidence in five continents vol. VIII. Lyon, France: IARC Scientific Publications, IARC.
16. Re: "Power-frequency electric and magnetic fields and risk of childhood leukemia in Canada". Am J Epidemiol 150: 223.
17. Ederer F, Axtell LM, Cutler SJ, (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6: 101-121.
18. Cutler SJ, Ederer F, (1958) Maximum utilization of the life table method in analyzing survival. J Chronic Dis 8: 699-712.
19. Ederer F, Heise H (1959) Instructions to IBM 650 programmers in processing survival computations. methodological note no. 10, end results evaluation section. Tech rep,National Cancer Institute, Bethesda, MD.
20. Hakulinen T, Seppa K, Lambert PC, (2011) Choosing the relative survival method for cancer survival estimation. Eur J Cancer 47: 2202-2210.
21. Corazziari I, Quinn M, Capocaccia R, (2004) Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40: 2307-2316.
22. Gunawardana C, Austen B, Powell JE, Fegan C, Wandroo F, et al. (2008) South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients. Br J Haematol 142: 606-609.
23. Wu SJ, Lin CT, Huang SY, Lee FY, Liu MC,et al. Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence- clinical implication and comparison between the West and the East. Ann Hematol. (in press).
24. Ng KP, Hillmer AM, Chuah CT, Juan WC, Ko TK, et al. (2012) A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer. Nat Med 18: 521-528.
25. Wang J, Zhou JY, Wu GS, (2011) Bim protein degradation contributes to cisplatin resistance. J Biol Chem 286: 22384-22392.
26. Li Z, Zhang J, Liu Z, Woo CW, Thiele CJ, (2007) Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death. Cell Death Differ 14: 318-326.
27. Richter-Larrea JA, Robles EF, Fresquet V, Beltran E, Rullan AJ, et al. (2010) Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma. Blood 116: 2531-2542.
28. Zantl N, Weirich G, Zall H, Seiffert BM, Fischer SF, et al. (2007) Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance. Oncogene 26: 7038-7048.
29. Lang HC, Lai MS, (2008) Willingness to pay to sustain and expand National Health Insurance services in Taiwan. BMC Health Serv Res 8: 261.
30. Lang HC, Lai MS, Chen GT, (2004) Outpatient drug expenditures and prescription policies for diseases with high cost to the National Health Insurance system in Taiwan. J Formos Med Assoc 103: 280-285.
31. Lin MC, Lai MS, (2009) Pediatricians' role in caring for preschool children in Taiwan under the national health insurance program. J Formos Med Assoc 108: 849-855.
32. Lin TS, Grever MR, Byrd JC, (2005) Changing the way we think about chronic lymphocytic leukemia. J Clin Oncol 23: 4009-4012.
33. Gribben JG (2008) New agents in chronic lymphocytic leukemia. Clin Adv Hematol Oncol 6: 409-410, 468.
34. Gribben JG, (2008) Role of allogeneic hematopoietic stem-cell transplantation in chronic lymphocytic leukemia. J Clin Oncol 26: 4864-4865.
35. Gribben JG, (2009) Stem cell transplantation in chronic lymphocytic leukemia. Biol Blood Marrow Transplant 15: 53-58.
36. Catovsky D, Fooks J, Richards S, (1989) Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults. Br J Haematol 72: 141-149.